Steven Girgenti

Mr. Steven Girgenti is an Executive Chairman at bioAffinity Technologies, Inc., an Executive Chairman at Pharmamatrix Acquisition Corp.
and a Managing Partner at Medi-Pharm Consulting LLC.
He is on the Board of Directors at AVTV Networks, Inc., Jack Martin Fund and Mount Sinai Hospital Prostate Disease & Research Center.
Mr. Girgenti was previously employed as an Independent Director by Hancock Jaffe Laboratories, Inc., an Independent Director by Vycor Medical, Inc., a Chairman & Chief Executive Officer by Ogilvy Healthworld, a Principal by Bristol Myers Squibb Co., a President, Chief Executive Officer & Director by DermWorx, Inc., a Principal by EIDP, Inc., a Chairman & Chief Executive Officer by Healthworld Corp., and a Principal by MedPointe, Inc. He also served on the board at Burren Pharmaceuticals, Inc. and Pharmacon International, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York and an MBA from The Trustees of Columbia University in The City of New York.